EE428 Budget Impact of Elranatamab-bcmm in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) in the United States
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.724
https://www.valueinhealthjournal.com/article/S1098-3015(24)00839-8/fulltext
Title :
EE428 Budget Impact of Elranatamab-bcmm in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) in the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00839-8&doi=10.1016/j.jval.2024.03.724
First page :
Section Title :
Open access? :
No
Section Order :
10196